// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often preven",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "EFO DDA dissociation method sex PRIDE:0000834 biosample accession number DIA BE developmental stage ANY PATO:0000461 INITIATIVE SH PO age MS:1001251 CID PMID fraction identifier organism REQUIRED IMPLIED TAB FITNESS SILAC RECOMMENDED STANDARDS INFORMATION JA label THE OPTIONAL README OR ID SWATH RAW BUT ancestry category SAMEA PS mass pooled sample SRM AS PEPTIDESEQ NCE PRIDE organism part IAA LC BTO REQUIRES HTML LIMITED IMPORTANT NCIT:C25714 PSI FDR NOTE IDF PRIDE:0000833 FOR exclamation PRIDE:0000831 CV ROW NCI PROTEOMICS depletion PURPOSE URL CF ZFA MAY PMCID III HCD file your PP SP SAMN HANCESTRO disease MHC collision energy II UBERON PARTICULAR CS NCIT:C25683 RFC NCBI VK CPTAC MOD DJ reduction reagent ISA instrument PATO MIAME CLO CELL AC alkylation reagent cell type EW LI HF ... cleavage agent details MAJOR EXPRESS BMC NOT MC characteristics TMT MS spiked compound URI MT INFRINGE MAGE SHALL PRM MERCHANTABILITY NT RIGHTS NCIT sample HEREIN technical replicate THAT fractionation method CT proteomics data acquisition method MONDO CL PRIDE:0000659 QY ALL TO IS data file INCLUDING TIP MINOR XL WARRANTIES WILL USE source name VCF COULD HUPO SDRF EBI RECOMMEND biological replicate BRENDA OF MUST SHOULD TA PRIDE:0000832 PTM WARRANTY SN COLUMN XML ENVO DTT PATCH EM individual DISCLAIMS CN"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often preven",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "EFO DDA dissociation method PRIDE:0000834 biosample accession number DIA BE ANY PATO:0000461 INITIATIVE SH PO age MS:1001251 CID PMID fraction identifier organism REQUIRED IMPLIED TAB FITNESS SILAC RECOMMENDED STANDARDS INFORMATION JA label THE OPTIONAL README OR SWATH BUT RAW SAMEA PS mass pooled sample SRM AS PEPTIDESEQ NCE PRIDE organism part IAA LC BTO REQUIRES HTML LIMITED NCIT:C25714 PSI FDR IDF PRIDE:0000833 FOR PRIDE:0000831 CV ROW NCI PROTEOMICS depletion PURPOSE URL CF ZFA MAY PMCID III HCD PP SP SAMN HANCESTRO disease MHC collision energy II UBERON PARTICULAR CS NCIT:C25683 RFC NCBI VK CPTAC MOD DJ reduction reagent ISA instrument PATO MIAME CLO CELL AC alkylation reagent cell type EW LI HF ... cleavage agent details MAJOR EXPRESS BMC NOT MC TMT MS spiked compound URI MT INFRINGE MAGE SHALL PRM MERCHANTABILITY NT RIGHTS NCIT HEREIN technical replicate THAT fractionation method CT proteomics data acquisition method MONDO CL PRIDE:0000659 QY ALL TO IS data file INCLUDING MINOR XL WARRANTIES WILL USE VCF COULD HUPO SDRF EBI RECOMMEND biological replicate BRENDA OF MUST SHOULD TA PRIDE:0000832 PTM WARRANTY SN COLUMN ENVO DTT PATCH EM individual DISCLAIMS CN"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nDisease\n\nColumn: characteristics[disease]\n\nOntology: MONDO Disease Ontology (preferred), EFO, Human Disease Ontology (DOID)\n\nHealthy Samples: normal vs healthy vs control\n\nFor samples without disease, the terminology matters for standardization:\n\nnormal (PATO:0000461) - Recommended\n\n- S",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "EFO CL:0000084 NCBI organism part MONDO CL:0000066 CL synthetic peptide UBERON:0000178 developmental stage PATO PATO:0000461 PO age NOTE organism cell type exclamation depletion SDRF APP MONDO:0004989 enrichment process UBERON:0002107 MAY MUST ID xenograft PATO:0001421 MONDO:0004975 PTM CL:0000815 UBERON PDX disease CL:0000624 MONDO:0005148 DOID"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nDisease\n\nColumn: characteristics[disease]\n\nOntology: MONDO Disease Ontology (preferred), EFO, Human Disease Ontology (DOID)\n\nHealthy Samples: normal vs healthy vs control\n\nFor samples without disease, the terminology matters for standardization:\n\nnormal (PATO:0000461) - Recommended\n\n- S",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "EFO CL:0000084 NCBI organism part MONDO CL:0000066 CL synthetic peptide UBERON:0000178 developmental stage PATO PATO:0000461 PO age organism cell type depletion SDRF APP MONDO:0004989 enrichment process UBERON:0002107 MAY MUST ID xenograft PATO:0001421 MONDO:0004975 PTM CL:0000815 UBERON PDX disease CL:0000624 MONDO:0005148 DOID"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "smoking status organism part HIPAA sampling time point MONDO NCIT:C18206 TNM staging PR dose NCIT:C28078 ER body mass index HANCESTRO:0009 NCIT:C71732 IMPORTANT treatment compound MONDO:0005044 treatment response GDPR weight NCIT:C15262 tumor grade exclamation NCI NCIT:C4870 NCIT:C65108 Dukes stage breast cancer subtype SDRF TNM CHEBI:27899 treatment status NCIT:C28076 CHEBI:28748 Ann Arbor stage menopausal status disease stage AJCC ID ancestry category NCIT:C53554 HANCESTRO:0005 NCIT:C65107 pre-existing condition NCIT HANCESTRO IV NCIT:C15632 NCIT:C65106 individual NCIT:C27971 NCIT:C27966 MONDO:0005148"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "smoking status organism part HIPAA sampling time point MONDO NCIT:C18206 TNM staging PR dose NCIT:C28078 ER body mass index HANCESTRO:0009 NCIT:C71732 treatment compound treatment response MONDO:0005044 weight GDPR NCIT:C15262 tumor grade NCI NCIT:C4870 NCIT:C65108 Dukes stage breast cancer subtype SDRF TNM CHEBI:27899 treatment status NCIT:C28076 CHEBI:28748 Ann Arbor stage menopausal status disease stage AJCC ID ancestry category NCIT:C53554 HANCESTRO:0005 NCIT:C65107 pre-existing condition NCIT HANCESTRO IV NCIT:C15632 NCIT:C65106 individual NCIT:C27971 NCIT:C27966 MONDO:0005148"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Analyzer Type\n\nColumn: comment[MS2 analyzer type]\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nValues: orbitrap, ion trap, quadrupole.\n\nDIA Scan Window\n\nColumn: comment[MS1 scan range]\n\nFormat: {lower}m/z - {upper}m/z (e.g., 400m/z - 1200m/z)\n\nAlternative: Use comment[scan window lower limit] and comment[scan window upper limit] as separate columns.\n\nProtein Modifications\n\nColumn: comment[modification parameters]\n\nFormat: Key=value pairs: NT=ModificationName;AC=Accession;MT=Type;TA=AminoAcid;PP=Position\n\nProperty |Key |Description\n\nName |NT |Modification name (UNIMOD or PSI-MOD)\nAccession |AC |UNIMOD or PSI-MOD accession\n\nCommon modifications:\n\nModification |Value\n\nCarbamidomethyl (fixed) |NT=Carbamidomethyl;AC=UNIMOD:4;MT=Fixed;TA=C\nOxidation (variable) |NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M\n\nCleavage Agents\n\nColumn: comment[cleavage agent details]\n\nREQUIRED.\n\nFormat: NT=EnzymeName;AC=Accession\n\nEnzyme |Value\n\nTrypsin |NT=Trypsin;AC=MS:1001251\nLys-C |NT=Lys-C;AC=MS:1001309\n\nFor top-down/intact proteins, use not applicable. For multiple enzymes, add multiple columns.\n\nMass Tolerances\n\nColumns: comment[precursor mass tolerance], comment[fragment mass tolerance]\n\nForm",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "PRIDE UNIMOD MS2 analyzer type DIA MOD MS:1001309 precursor mass tolerance PSI AC MS:1001251 REQUIRED cleavage agent details exclamation fragment mass tolerance SILAC SDRF scan window upper limit label TMT MS MS1 scan range README MT TA UNIMOD:35 PP UNIMOD:4 modification parameters NT scan window lower limit"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Analyzer Type\n\nColumn: comment[MS2 analyzer type]\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nValues: orbitrap, ion trap, quadrupole.\n\nDIA Scan Window\n\nColumn: comment[MS1 scan range]\n\nFormat: {lower}m/z - {upper}m/z (e.g., 400m/z - 1200m/z)\n\nAlternative: Use comment[scan window lower limit] and comment[scan window upper limit] as separate columns.\n\nProtein Modifications\n\nColumn: comment[modification parameters]\n\nFormat: Key=value pairs: NT=ModificationName;AC=Accession;MT=Type;TA=AminoAcid;PP=Position\n\nProperty |Key |Description\n\nName |NT |Modification name (UNIMOD or PSI-MOD)\nAccession |AC |UNIMOD or PSI-MOD accession\n\nCommon modifications:\n\nModification |Value\n\nCarbamidomethyl (fixed) |NT=Carbamidomethyl;AC=UNIMOD:4;MT=Fixed;TA=C\nOxidation (variable) |NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M\n\nCleavage Agents\n\nColumn: comment[cleavage agent details]\n\nREQUIRED.\n\nFormat: NT=EnzymeName;AC=Accession\n\nEnzyme |Value\n\nTrypsin |NT=Trypsin;AC=MS:1001251\nLys-C |NT=Lys-C;AC=MS:1001309\n\nFor top-down/intact proteins, use not applicable. For multiple enzymes, add multiple columns.\n\nMass Tolerances\n\nColumns: comment[precursor mass tolerance], comment[fragment mass tolerance]\n\nForm",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "PRIDE UNIMOD MS2 analyzer type DIA MOD MS:1001309 precursor mass tolerance PSI AC MS:1001251 REQUIRED cleavage agent details fragment mass tolerance SILAC SDRF scan window upper limit label TMT MS MS1 scan range MT TA UNIMOD:35 PP UNIMOD:4 modification parameters NT scan window lower limit"
  }
];
